Wenting Wu is an accomplished statistician with extensive experience in the pharmaceutical industry. Currently serving as Executive Director of Statistics at Eli Lilly and Company since September 2024, Wenting has held various prominent roles, including Statistical Science Director for Oncology at AstraZeneca and Vice President of Biometrics at POINT Biopharma. Wenting's career also includes significant positions at Mayo Clinic as Lead Faculty Statistician and as both a Principal and Global Product Statistician at AstraZeneca. Early career experience includes working as an intern and statistical consultant at Baxter International Inc. Wenting Wu earned a Ph.D. in Mathematics and Statistics from the University of Illinois Chicago in 2006.
This person is not in the org chart
This person is not in any teams
This person is not in any offices